Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Valens Company Inc (The) Ordinary Shares VLNCF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
The Valens Co Inc is a developer and manufacturer of cannabinoid-based products. The company's extraction methods are CO2, ethanol, hydrocarbon, solvent-less, and terpene extraction. Its products are Tinctures, Capsules, Beverages, and Vape cartridges among others. Its reportable segments are Cannabis operations, Analytical testing, and Corporate. The company has a business presence in Canada... see more

Recent & Breaking News (OTCQX:VLNCF)

The Valens Company Continues to Expand Canadian Recreational Market Share in April

PR Newswire May 25, 2022

The Valens Company Appoints New Board Chair and Provides an Update on its Annual General Meeting of Shareholders

PR Newswire May 16, 2022

The Valens Company to Participate in Upcoming Investor Conferences

PR Newswire May 4, 2022

The Valens Company to Participate in AGP Spring Consumer Cannabis Conference

PR Newswire April 27, 2022

The Valens Company Secures Agreement for Green Roads Kiosks in Major Malls Across the United States

PR Newswire April 21, 2022

The Valens Company Reports First Quarter Fiscal 2022 Financial Results

PR Newswire April 13, 2022

The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2022

PR Newswire April 7, 2022

The Valens Company Issues Letter to Shareholders & Announces Initiation of Second Wave of Integration Initiatives to Increase Efficiencies and Drive Additional Cost Savings

PR Newswire April 5, 2022

The Valens Company Closes Previously Announced Bought Deal Financing Including Exercise of Over-Allotment Option

PR Newswire April 5, 2022

IIROC Trade Resumption - VLNS

Canada NewsWire March 30, 2022

The Valens Company Announces Approximately USD$22.5 Million Bought Deal Offering of Units

Canada NewsWire March 29, 2022

IIROC Trading Halt - VLNS

Canada NewsWire March 29, 2022

The Valens Company Continues to Grow National Market Share

PR Newswire March 16, 2022

The Valens Company Reports Fourth Quarter and Fiscal Year 2021 Financial Results

PR Newswire February 28, 2022

The Valens Company to Hold Conference Call to Discuss Financial Results for the Fourth Quarter and Fiscal Year 2021

PR Newswire February 17, 2022

The Valens Company Begins Manufacturing Cannabis-Infused Beverages at Greater Toronto Area Facility & Signs Manufacturing Partnership

PR Newswire February 10, 2022

The Valens Company Announces Integration Initiative After Acquisitive 2021

PR Newswire February 2, 2022

The Valens Company to Host Investor Day

PR Newswire January 31, 2022

The Valens Company Launches Two New Brands in Value and Premium Markets

PR Newswire January 25, 2022

Green Roads Launches 'Own the Day' Brand Campaign

PR Newswire January 19, 2022